POP Medical (formerly Pro Access) has obtained approval from the US Food and Drug Administration (FDA) for marketing of its medical device for treatment of pelvic floor prolapse. 20% of the women in the world suffer from this condition at any given moment, and 30% at some time in their lives. The condition causes internal organs to exert pressure on the pelvic floor, which can lead to repeat urinary tract infections, vaginal bleeding, pain, discomfort in sexual relations, etc. The accepted treatment was formerly a hysterectomy. In recent years, solutions involving anchoring through an alternative artificial pelvic floor have been developed, but these do not last, and feature bleeding and other side effects.
